These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34597850)

  • 1. Appraisal of the Real-World Effectiveness of Biologic Therapies in Aspirin-Exacerbated Respiratory Disease.
    Wangberg H; Spierling Bagsic SR; Osuna L; White AA
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):478-484.e3. PubMed ID: 34597850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin-exacerbated respiratory disease: Updates in the era of biologics.
    Mullur J; Buchheit KM
    Ann Allergy Asthma Immunol; 2023 Sep; 131(3):317-324. PubMed ID: 37225000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biologic therapy in patients with severe NSAID-exacerbated respiratory disease and previous aspirin desensitization : Results of a multicentric study].
    Staufenberg AR; Frankenberger HK; Förster-Ruhrmann U; Spahn FC; Klimek L; Fruth K; Stihl C; Matthias C; Gröger M; Hagemann J
    HNO; 2024 Jul; 72(7):473-483. PubMed ID: 38466409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal polyp antibody-secreting cells display proliferation signature in aspirin-exacerbated respiratory disease.
    Sohail A; Hacker J; Ryan T; McGill A; Bergmark R; Bhattacharyya N; Lee SE; Maxfield A; Roditi R; Julé AM; Griffith A; Lederer J; Laidlaw TM; Buchheit KM
    J Allergy Clin Immunol; 2024 Feb; 153(2):527-532. PubMed ID: 37898408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-5Rα marks nasal polyp IgG4- and IgE-expressing cells in aspirin-exacerbated respiratory disease.
    Buchheit KM; Dwyer DF; Ordovas-Montanes J; Katz HR; Lewis E; Vukovic M; Lai J; Bankova LG; Bhattacharyya N; Shalek AK; Barrett NA; Boyce JA; Laidlaw TM
    J Allergy Clin Immunol; 2020 Jun; 145(6):1574-1584. PubMed ID: 32199912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease.
    Buchheit KM; Sohail A; Hacker J; Maurer R; Gakpo D; Bensko JC; Taliaferro F; Ordovas-Montanes J; Laidlaw TM
    J Allergy Clin Immunol; 2022 Aug; 150(2):415-424. PubMed ID: 35460728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should Biologics Be Used Before Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease?
    Laidlaw TM; White AA
    J Allergy Clin Immunol Pract; 2024 Jan; 12(1):79-84. PubMed ID: 37778627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis.
    Geng B; Dilley M; Anterasian C
    Curr Allergy Asthma Rep; 2021 Jun; 21(6):36. PubMed ID: 34110505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal Anti-inflammatory Drug (NSAID) Tolerance After Biological Therapy in Patients With NSAID-Exacerbated Respiratory Disease: A Randomized Comparative Trial.
    Sánchez J; García E; Lopez JF; Calle A; Buendia JA
    J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2172-2179. PubMed ID: 37146885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies in Allergy: Aspirin Desensitization or Biologics for Aspirin-Exacerbated Respiratory Disease-How to Choose.
    Laidlaw TM; Chu DK; Stevens WW; White AA
    J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1462-1467. PubMed ID: 34999274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease.
    Buchheit KM; Lewis E; Gakpo D; Hacker J; Sohail A; Taliaferro F; Berreondo Giron E; Asare C; Vukovic M; Bensko JC; Dwyer DF; Shalek AK; Ordovas-Montanes J; Laidlaw TM
    J Allergy Clin Immunol; 2021 Aug; 148(2):574-584. PubMed ID: 34144111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: A real-world study.
    Bajpai S; Marino MJ; Rank MA; Donaldson AM; O'Brien EK; Lal D
    Int Forum Allergy Rhinol; 2021 Aug; 11(8):1152-1161. PubMed ID: 33527730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-Life Experience of Biologic Treatment for Asthma on Chronic Rhinosinusitis: A Finnish Cohort.
    Lyly A; Genberg E; Kauppi P; Virkkula P; Lee SE; Laidlaw TM; Toppila-Salmi S; Lundberg M
    Int Arch Allergy Immunol; 2023; 184(2):149-160. PubMed ID: 36349770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the timing of biologic and surgical therapy for patients with refractory chronic rhinosinusitis with nasal polyposis (CRSwNP).
    Garvey E; Naimi B; Duffy A; Hannikainen P; Kahn C; Farquhar D; Rosen M; Rabinowitz M; Toskala E; Nyquist G
    Int Forum Allergy Rhinol; 2024 Mar; 14(3):651-659. PubMed ID: 37506043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?
    O'Brien EK; Jerschow E; Divekar RD
    Otolaryngol Clin North Am; 2024 Apr; 57(2):265-278. PubMed ID: 37833102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study.
    Cooper T; Greig SR; Zhang H; Seemann R; Wright ED; Vliagoftis H; Côté DWJ
    Auris Nasus Larynx; 2019 Aug; 46(4):526-532. PubMed ID: 30577986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin-exacerbated respiratory disease and current treatment modalities.
    Sakalar EG; Muluk NB; Kar M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New concepts for the pathogenesis and management of aspirin-exacerbated respiratory disease.
    Sehanobish E; Asad M; Jerschow E
    Curr Opin Allergy Clin Immunol; 2022 Feb; 22(1):42-48. PubMed ID: 34739410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dupilumab as Add-on Therapy for Chronic Rhinosinusitis With Nasal Polyposis in Aspirin Exacerbated Respiratory Disease.
    Mustafa SS; Vadamalai K; Scott B; Ramsey A
    Am J Rhinol Allergy; 2021 May; 35(3):399-407. PubMed ID: 32967430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease.
    Stevens WW; Peters AT; Hirsch AG; Nordberg CM; Schwartz BS; Mercer DG; Mahdavinia M; Grammer LC; Hulse KE; Kern RC; Avila P; Schleimer RP
    J Allergy Clin Immunol Pract; 2017; 5(4):1061-1070.e3. PubMed ID: 28286156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.